{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:39:32Z","timestamp":1790512772253,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198024","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T13:30:49Z","timestamp":1527600649000},"page":"e0198024","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3704-4600","authenticated-orcid":true,"given":"Uma","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiangos","family":"Yiangou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"MacQuillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sinisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri E.","family":"Korchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve R.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/gut.2009.194449","article-title":"Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain","volume":"59","author":"A Akbar","year":"2010","journal-title":"Gut"},{"key":"ref2","first-page":"347","article-title":"Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons","volume":"4","author":"Y Yiangou","year":"2011","journal-title":"J Pain Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/gut.2007.119446","article-title":"Guidelines on the irritable bowel syndrome: mechanisms and practical management","volume":"56","author":"R Spiller","year":"2007","journal-title":"Gut"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2007.138982","article-title":"Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain","volume":"57","author":"A Akbar","year":"2008","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"762191","DOI":"10.1155\/2014\/762191","article-title":"Determinants of weight loss prior to diagnosis in inflammatory bowel disease: a retrospective observational study","volume":"2014","author":"Y Elsherif","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of Glucagon-like peptide 1","volume":"87","author":"JJ Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1152\/ajpregu.00423.2003","article-title":"Sensory nerves contribute to insulin secretion by glucagon-like peptide 1 in mice","volume":"286","author":"B Ahren","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1139\/cjpp-2013-0025","article-title":"Effects of tumor necrosis factor \u03b1 on leptin-sensitive intestinal vagal mechanoreceptors in the cat","volume":"91","author":"N Quinson","year":"2013","journal-title":"Can J Physiol Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199205143262003","article-title":"Antidiabetogenic effect of glucagon-like peptide-1 (7\u201336) amide in normal subjects and patients with diabetes mellitus","volume":"326","author":"M Gutniak","year":"1992","journal-title":"N Engl J Med"},{"issue":"Pt 5","key":"ref10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1113\/jphysiol.2010.198069","article-title":"Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells","volume":"589","author":"G Rogers","year":"2011","journal-title":"J Physiol"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s001250051484","article-title":"Glucagon receptors on human islet cells contribute to glucose competence of insulin release","volume":"43","author":"P Huypens","year":"2000","journal-title":"Diabetlogica"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.44.1.81","article-title":"Glucagon-like peptide-1: a potent regulator of food intake in humans","volume":"44","author":"J Gutzweiller","year":"1999","journal-title":"Gut"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diaclin.31.4.148","article-title":"Practical use of glucagon-like peptide-1 receptor agonist therapy in primary care","volume":"31","author":"TS Reid","year":"2013","journal-title":"Clin Diabetes"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"DJ Drucker","year":"2006","journal-title":"Cell Metab"},{"issue":"8571","key":"ref15","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7\u201336: a physiological incretin in man","volume":"2","author":"B Kreymann","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"ref16","first-page":"R910","article-title":"GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans","volume":"277","author":"E Naslund","year":"1999","journal-title":"Am J Physiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"G424","DOI":"10.1152\/ajpgi.2002.282.3.G424","article-title":"Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans","volume":"282","author":"S Delgado-Aros","year":"2002","journal-title":"Am J Physiol Gastrointest LiverPhysiol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1210\/endo.142.10.8430","article-title":"Oxyntomodulin inhibits food intake in the rat","volume":"142","author":"CL Dakin","year":"2001","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/sj.ijo.0803344","article-title":"Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled tria","volume":"30","author":"K Wynne","year":"2006","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumours and human normal tissues: potential for in vivo targeting","volume":"48","author":"M Korner","year":"2007","journal-title":"J Nuclear Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/JOE-13-0525","article-title":"Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle","volume":"221","author":"A Amato","year":"2014","journal-title":"J Endocrinol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/MIB.0000000000000847","article-title":"GLP-1 induces barrier protective expression in Brunner\u2019s glands and regulates colonic inflammation","volume":"22","author":"CH Bang-Berthelson","year":"2016","journal-title":"Inflam Bowel Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2982.2010.01476.x","article-title":"Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors","volume":"22","author":"A Amato","year":"2010","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody","volume":"155","author":"C Pyke","year":"2014","journal-title":"Endocrinology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide 1-receptor is involved in learning and neuroprotection","volume":"9","author":"MJ During","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1167\/iovs.09-4727","article-title":"Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats","volume":"52","author":"Y Zhang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"975032","DOI":"10.1155\/2013\/975032","article-title":"Retinal pigment epithelial cells express a functional receptor for glucagon-like peptide-1 (GLP-1)","volume":"2013","author":"A Puddu","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"44","key":"ref28","doi-asserted-by":"crossref","first-page":"10157","DOI":"10.1523\/JNEUROSCI.3247-05.2005","article-title":"Glucagon-expressing neurons within the retina regulate the proliferation of neural progenitors in the circumferential marginal zone of the avian eye","volume":"25","author":"AJ Fischer","year":"2005","journal-title":"J Neurosci"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"T Perry","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Pederson TA: Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase","volume":"136","author":"TJ Kieffer","year":"1995","journal-title":"IV. Endocrinology"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Richards P, Parker HE, Adrienssens AE, Hodgson JM, Cork SC, Trapp S, et al. Identification and characterisation of glucagon-like peptide 1 receptor expressing cells using a new transgenic mouse model. Diabetes 2014;63(4):1224\u201333.","DOI":"10.2337\/db13-1440"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2337\/db10-1462","article-title":"Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice","volume":"60","author":"T Himeno","year":"2011","journal-title":"Diabetes"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/j.1532-2149.2012.00269.x","article-title":"Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons","volume":"17","author":"U Anand","year":"2013","journal-title":"Eur J Pain"},{"issue":"1\u20132","key":"ref34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2006.01.046","article-title":"The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons","volume":"399","author":"U Anand","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1210\/endo-126-4-2164","article-title":"Glucagon-like peptide 1 analogs: effects on insulin secretion and adenosine 3\u2019-5\u2019cyclic monophosphate formation","volume":"126","author":"D Gefel","journal-title":"Endocrinology1990"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1210\/endo.132.1.8380389","article-title":"The role of the free cytosolic calcium level in b-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide 1 (7\u201337)","volume":"132","author":"M Lu","year":"1993","journal-title":"Endocrinology"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nn840","article-title":"A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth","volume":"5","author":"HT Kao","year":"2002","journal-title":"Nat Neurosci"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrgastro.2013.29","article-title":"Extrinsic primary afferent signalling in the gut","volume":"10","author":"SJ Brookes","year":"2013","journal-title":"Nat Rev Gastroenerol Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-2982.2003.00456.x","article-title":"Characterization of the spinal primary afferent innervation of the mouse colon using retrograde labelling","volume":"16","author":"DR Robinson","year":"2004","journal-title":"Neurogastroenterol and Motil"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-13-0264","article-title":"Characterisation of oral and iv glucose handling in truncally vagotomised subjects with pyloroplasty","volume":"169","author":"A Plamboeck","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, Liraglutide and Exendin-4","volume":"152","author":"SE Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/gutjnl-2013-306235","article-title":"Recent advances in clinical practise challenges and opportunities in the management of obesity","volume":"63","author":"A Acosta","year":"2014","journal-title":"Gut"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000323399","article-title":"Luminal amino-acid sensing cells in gastric mucosa","volume":"83","author":"E Nakamura","year":"2011","journal-title":"Digestion"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fimmu.2016.00154","article-title":"Inflammation meets metabolic disease: gut feeling mediated by GLP-1","volume":"7","author":"T Zietek","year":"2016","journal-title":"Front Immunol"},{"issue":"45","key":"ref45","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/eci.12542","article-title":"Gastric emptying and disease activity in inflammatory bowel disease","author":"J Keller","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"1\u20133","key":"ref46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.regpep.2012.04.006","article-title":"Dipeptidyl peptidase-4 expression is reduced in Crohn's disease","volume":"177","author":"GW Moran","year":"2012","journal-title":"Regul Pept"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2982.2001.00276.x","article-title":"ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease","volume":"13","author":"Y Yiangou","year":"2001","journal-title":"Neurogastroentereol Motil"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"G120","DOI":"10.1152\/ajpgi.00076.2012","article-title":"Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome","volume":"303","author":"M Camilleri","year":"2012","journal-title":"Am J Gastrointest Liver Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T16:30:40Z","timestamp":1540312240000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198024"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198024","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]}}}